ANVS insider filings

Annovis Bio, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-06. Screen ANVS transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Hoffman Michael B — Director11 leg · 5,000,000 sh · $5,000,000—1

Recent insider filings — Annovis Bio, Inc.

FiledFormInsiderReported transactionsSource
2026-11-064Hoffman Michael B — DirectorPurchase (P): 5,000,000 @ $1 · Purchase (P): 5,000,000 (derivative) @ $0EDGAR
2026-05-214Hoffman Michael B — DirectorPurchase (P): 2,562 @ $1.75 · Purchase (P): 18,849 @ $1.80 · Purchase (P): 54,933 @ $1.90EDGAR
2026-04-034Hoffman Michael B — DirectorPurchase (P): 713,800 @ $2.10EDGAR
2025-12-084Hoffman Michael B — DirectorPurchase (P): 30,000 @ $4.34 · Purchase (P): 15,000 @ $4.24EDGAR
2025-11-254Hoffman Michael B — DirectorPurchase (P): 1,489 @ $4.13 · Purchase (P): 9,200 @ $3.85 · Purchase (P): 415 @ $4.14 · Purchase (P): 28,096 @ $4.15EDGAR
2025-11-254/AHoffman Michael B — DirectorPurchase (P): 1,489 @ $4.13 · Purchase (P): 9,200 @ $3.85 · Purchase (P): 415 @ $4.14 · Purchase (P): 28,096 @ $4.15EDGAR
2025-11-214Hoffman Michael B — DirectorPurchase (P): 10,000 @ $3.49 · Purchase (P): 10,000 @ $3.50EDGAR
2025-11-184Hoffman Michael B — DirectorPurchase (P): 15,000 @ $2.11EDGAR
2025-11-124Bruck Claudine — DirectorOption exercise (M): 7,142 @ $0.14 · Option exercise (M): 7,142 (derivative) @ $0EDGAR
2025-11-124Maccecchini Maria-Luisa — President & CEO, DirectorPurchase (P): 97,561 @ $2.05EDGAR
2025-11-124Hoffman Michael B — DirectorPurchase (P): 975,610 @ $2.05EDGAR
2025-09-034Hoffman Michael B — DirectorGrant/award (A): 5,000 @ $2.28 · Grant/award (A): 5,000 @ $2.29 · Grant/award (A): 5,000 @ $2.30EDGAR
2025-08-204Hoffman Michael B — DirectorGrant/award (A): 6,717 @ $2.60 · Grant/award (A): 5,283 @ $2.59 · Grant/award (A): 5,545 @ $2.58 · Grant/award (A): 1,100 @ $2.57EDGAR
2025-06-184Walsh Andrew — Vice President, FinanceGrant/award (A): 500 @ $2.90EDGAR
2025-06-164Hoffman Michael B — DirectorGrant/award (A): 25,000 @ $2.80 · Grant/award (A): 1 @ $2.83EDGAR
2025-06-114McCarthy Reid — DirectorGrant/award (A): 2,000 @ $2.95EDGAR
2025-06-054Maccecchini Maria-Luisa — President & CEO, DirectorGrant/award (A): 46,000 @ $3.37EDGAR
2025-06-024Hoffman Michael B — DirectorGrant/award (A): 5,000 @ $2.43EDGAR
2024-07-034White Mark K. — DirectorGrant/award (A): 26,200 (derivative) @ $0 · Grant/award (A): 2,146 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2024-07-034McCarthy Reid — DirectorGrant/award (A): 29,600 (derivative) @ $0EDGAR
2024-07-034Bruck Claudine — DirectorGrant/award (A): 26,200 (derivative) @ $0EDGAR
2024-07-034Maccecchini Maria-Luisa — President and CEO, Director, 10% ownerGift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0 · Grant/award (A): 252,000 (derivative) @ $0 · Grant/award (A): 108,800 (derivative) @ $0EDGAR
2024-07-034Hoffman Michael B — Director, 10% ownerGrant/award (A): 29,600 (derivative) @ $0EDGAR
2023-11-224/AWhite Mark K. — DirectorGrant/award (A): 1,990 @ $6.10EDGAR
2023-11-224/AMcCarthy Reid — DirectorOther (J): 0 @ $0EDGAR
2023-11-224/AHagopian Henry III — Chief Financial OfficerGrant/award (A): 820 @ $6.10EDGAR
2023-11-224/ABruck Claudine — DirectorOther (J): 0 @ $0EDGAR
2023-11-224/AMaccecchini Maria-Luisa — President and CEO, Director, 10% ownerGrant/award (A): 40,970 @ $6.10EDGAR
2023-11-224/AHoffman Michael B — Director, 10% ownerGrant/award (A): 163,880 @ $6.10EDGAR
2023-11-214McCarthy Reid — DirectorGrant/award (A): 824 @ $6.07EDGAR
2023-11-214White Mark K. — DirectorGrant/award (A): 2,000 @ $6.07EDGAR
2023-11-214Hagopian Henry III — Chief Financial OfficerGrant/award (A): 824 @ $6.07EDGAR
2023-11-214Bruck Claudine — DirectorGrant/award (A): 1,000 @ $6.07EDGAR
2023-11-214Maccecchini Maria-Luisa — President and CEO, Director, 10% ownerGrant/award (A): 41,186 @ $6.07EDGAR
2023-11-214Hoffman Michael B — Director, 10% ownerGrant/award (A): 164,745 @ $6.07EDGAR
2023-04-264Maccecchini Maria-Luisa — President and CEO, Director, 10% ownerGift (G): 3,000 @ $0EDGAR
2023-04-114White Mark K. — DirectorGrant/award (A): 3,000 @ $12.61EDGAR
2023-04-114Bruck Claudine — DirectorGrant/award (A): 500 @ $12.61EDGAR
2023-04-114Hagopian Henry III — Chief Financial OfficerGrant/award (A): 1,000 @ $12.61EDGAR
2023-04-114McCarthy Reid — DirectorGrant/award (A): 476 @ $12.61EDGAR
2023-04-114Maccecchini Maria-Luisa — President and CEO, Director, 10% ownerGrant/award (A): 20,000 @ $12.61EDGAR
2023-04-114Hoffman Michael B — Director, 10% ownerGrant/award (A): 59,477 @ $12.61EDGAR
2023-02-084Maccecchini Maria-Luisa — President and CEO, Director, 10% ownerOption exercise (M): 52,755 @ $0.14 · Option exercise (M): 52,755 (derivative) @ $0EDGAR
2023-01-204Hagopian Henry III — Chief Financial OfficerGrant/award (A): 7,672 (derivative) @ $0EDGAR
2023-01-204White Mark K. — DirectorGrant/award (A): 5,967 (derivative) @ $0EDGAR
2023-01-204McCarthy Reid — DirectorGrant/award (A): 5,967 (derivative) @ $0EDGAR
2023-01-204Bruck Claudine — DirectorGrant/award (A): 5,967 (derivative) @ $0EDGAR
2023-01-204Maccecchini Maria-Luisa — President and CEO, Director, 10% ownerGrant/award (A): 21,312 (derivative) @ $0EDGAR
2023-01-204Hoffman Michael B — Director, 10% ownerGrant/award (A): 6,820 (derivative) @ $0EDGAR
2022-08-314Hagopian Henry III — Chief Financial OfficerGrant/award (A): 120,000 (derivative) @ $0EDGAR

Recent 8-K events — Annovis Bio, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-058-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-048-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-048-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
8.01 — Other Events
EDGAR
2026-10-308-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-208-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-108-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-178-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-208-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ANVS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs